A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole

NCT01786382 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic Assessments in Healthy Volunteers

Interventions

DRUG: PPI-668
DRUG: Midazolam
DRUG: Omeprazole
DRUG: Telaprevir

Sponsor

Presidio Pharmaceuticals, Inc.